Stockreport

Sesen Bio Announces Acceptance of Analytical Comparability Plan by the U.S. Food and Drug Administration to Support the BLA and Commercialization of Its Lead Asset, Vicinium® for Non-Muscl...

Sesen Bio, Inc.  (SESN) 
Last sesen bio, inc. earnings: 11/12 07:00 am Check Earnings Report
PDF CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatme [Read more]